First-Line Treatment for Bacterial Bronchitis and Pneumonia

Bacterial Bronchitis Treatment

The European Respiratory Society recommends that in otherwise healthy adults, immediate antibiotic therapy is generally not recommended for simple acute bronchitis, even with fever present, as most cases are viral in origin 3
The American Thoracic Society suggests that antibiotic therapy should only be initiated if fever (>38°C) persists for more than 3 days 3, 4
For patients with infrequent exacerbations and FEV1 >35%, the European Respiratory Society recommends that amoxicillin remains the reference treatment 3, 4
The Infectious Diseases Society of America recommends alternative first-line options for patients with beta-lactam allergies, including macrolides, pristinamycin, or doxycycline 3
For patients with chronic obstructive bronchitis (FEV1 between 35-80%), the American College of Chest Physicians recommends that immediate antibiotic therapy is only recommended if at least two of the three Anthonisen criteria are present (increased sputum volume, increased sputum purulence, increased dyspnea) 3, 4

The Infectious Diseases Society of America recommends that amoxicillin (3 g/day) is the reference treatment for pneumococcal pneumonia in adults without risk factors 1, 2
For patients with risk factors or suspected atypical pathogens, the American Thoracic Society recommends treatment options including amoxicillin-clavulanate, parenteral 2nd or 3rd generation cephalosporins, and respiratory fluoroquinolones active against S. pneumoniae 1, 2
For children under 3 years, the American Academy of Pediatrics recommends that amoxicillin (80-100 mg/kg/day in three daily doses) is the initial treatment of choice 1, 6
For children over 3 years, the American Academy of Pediatrics recommends that if pneumococcal infection is suspected, amoxicillin is the reference treatment 5

The European Respiratory Society recommends that for bronchitis exacerbations, treatment duration should be 5-8 days 1, 3
The Infectious Diseases Society of America recommends that for community-acquired pneumonia in adults, treatment duration should be 7-14 days 2
The American Academy of Pediatrics recommends that for community-acquired pneumonia in children, treatment duration should be 5-8 days 1

The American College of Chest Physicians recommends that therapeutic efficacy should be assessed within 48-72 hours after initiating treatment 2
The Infectious Diseases Society of America recommends that treatment should not be changed within the first 72 hours unless the patient's clinical condition worsens 2
The European Respiratory Society recommends that failure of amoxicillin treatment may indicate infection with beta-lactamase producing organisms 5

The American Thoracic Society recommends that treating all bronchitis cases with antibiotics despite most being viral in origin should be avoided 3
The Infectious Diseases Society of America recommends that using fluoroquinolones as first-line therapy when narrower-spectrum antibiotics would be appropriate should be avoided 3
The European Respiratory Society recommends that using antibiotics with poor activity against S. pneumoniae (such as ciprofloxacin or cefixime) for respiratory infections should be avoided 3